Nanologica AB (publ) announced that it delivers silica to an insulin manufacturer in Asia against an order received last year. The delivery consisists of silica for evaluation in full-scale production. The delivery is made against an order that was placed last year and Nanologica will provide the silica free of charge in return for being provided with results and insights into the final evaluation.

The customer, which is one of the world's largest insulin manufacturers, finances all other costs for full-scale production evaluation. In the event of a positive outcome, Nanologica expects negotiations on deliveries over a long period of time and starting within one year. A number of customers have successfully evaluated Nanologica's silica for preparative chromatography, NLAB Saga®, on a smaller scale.

Last year, the company took several orders for large-scale evaluation.